New Clinical Utility Data Confirm Veracyte’s Envisia Genomic Classifier Increases Accuracy and Confidence in IPF Diagnosis

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Data to be presented at CHEST show Veracyte's Envisia Genomic Classifier positively impacts clinical decision-making in idiopathic pulmonary fibrosis.

Click to view original post